肝细胞癌早期与晚期复发再次肝切除的多中心倾向评分匹配分析
该多中心研究比较肝细胞癌初次肝切除后早期复发(1年内)与晚期复发患者接受根治性再次肝切除的长期肿瘤学结局。倾向评分匹配后,早期复发组5年总生存率和无病生存率均劣于晚期复发组,早期复发是多因素Cox回归中总生存与无病生存的独立不良因素。
要点
- 再次肝切除对复发性肝细胞癌可行,但早期复发者生存获益明显差于晚期复发者
- 早期复发定义为初次肝切除后1年内复发
- 早期复发是总生存与无病生存的独立不良预后因素,可用于患者选择与知情沟通
核心结论
- 肝细胞癌早期复发患者再次肝切除的总生存与无病生存均劣于晚期复发患者。
- 该数据有助于为复发性肝细胞癌患者是否行再次肝切除的筛选与沟通提供依据。
研究设计与样本
- 多中心数据库回顾性研究,纳入接受根治性再次肝切除的复发性肝细胞癌患者。
- 以初次肝切除后1年为界定义早期与晚期复发;早期复发81例,晚期复发129例。
- 采用倾向评分匹配分析,匹配后纳入74对患者。
主要发现
- 倾向评分匹配前,早期复发组再次切除后5年总生存率为41.7%、无病生存率为17.9%,均差于晚期复发组的57.0%和39.4%(均P < .01)。
- 倾向评分匹配后,早期复发组5年总生存率和无病生存率分别为41.0%和19.2%,晚期复发组为64.3%和43.2%(均P < .01)。
- 多因素Cox回归校正其他混杂因素后,早期复发仍与总生存下降独立相关(风险比2.22,95%CI 1.35-3.34,P = .001)。
- 多因素Cox回归校正其他混杂因素后,早期复发仍与无病生存下降独立相关(风险比1.86,95%CI 1.26-2.74,P = .002)。
临床怎么用
- 对肝细胞癌术后1年内早期复发者考虑再次肝切除时,应充分评估获益并告知其预后劣于晚期复发。
- 可将早期复发作为再次肝切除患者选择与知情沟通的重要参考因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Repeat hepatectomy is a feasible treatment modality for intrahepatic recurrence after hepatectomy of hepatocellular carcinoma, yet the survival benefit remains ill-defined. The objective of the current study was to define long-term, oncologic outcomes after repeat hepatectomy among patients with early and late recurrence. METHODS: Patients undergoing curative-intent repeat hepatectomy for recurrent hepatocellular carcinoma were identified using a multi-intuitional database. Early and late recurrence was defined by setting 1 year after initial hepatectomy as the cutoff value. Patient clinical characteristics, overall survival, and disease-free survival were compared among patients with early and late recurrence before and after propensity score matching. RESULTS: Among all the patients, 81 had early recurrence and 129 had late recurrence from which 74 matched pairs were included in the propensity score matching analytic cohort. Before propensity score matching, 5-year overall survival and disease-free survival after resection of an early recurrence were 41.7% and 17.9%, respectively, which were worse compared with patients who had resection of a late recurrence (57.0% and 39.4%, both P < .01). After propensity score matching, 5-year overall survival and disease-free survival among patients with early recurrence were worse compared with patients with late recurrence (41.0% and 19.2% vs 64.3% and 43.2%, both P < .01). After adjustment for other confounding factors on multivariable Cox-regression analysis, early recurrence remained independently associated with decreased overall survival and disease-free survival (hazard ratio 2.22, 95% confidence interval 1.35-3.34, P = .001; hazard ratio 1.86, 95% confidence 1.26-2.74, P = .002). CONCLUSION: Repeat hepatectomy for early recurrence was associated with worse overall survival and disease-free survival compared with late recurrence. These data may help inform patients and selection of patients being considered for repeat hepatectomy of recurrent hepatocellular carcinoma.
引用
- Xing H, Sun LY, Yan WT, et al. Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis. Surgery. 2019. PMID: 31879090. doi:10.1016/j.surg.2019.11.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。